Story

The company "Reb-Pharma" was established in 2013.

In 2014 the company signed an Investment Agreement No.ID-1754 dated on December 8, 2014 with the Republic of Belarus within the framework of an investment project implemented on  reconstruction of the existing production facilities for drugs manufacturing in the village Smilovichi located in Chervensky district.

At the end of 2014, as a part of the investment project, the first stage of the secondary packaging workshop reconstruction started in the village of Smilovichi located in Chervensky district and launched in 2015.

GMP Certificate was obtained in February 2017, then the company's own Control and Analytical Laboratory furnished with the state-of-the-art equipment was built. The company performes the finished product release quality control.

In March 2018 the aerosol and liquid non-sterile dosage forms workshop was put into operation, where a wide range of pharmaceuticals produced in a full cycle will be launched in a future.

At present the enterprise has already launched the production of more than 50 types of medicinal products including those that have no analogues in the Republic of Belarus:

-              Hepasoft (Sofosbuvir) – for Hepatitis C treatment

-              Daclasoft (Daclatosvir) - for Hepatitis C treatment 

-              Reblax in capsules 4 mg, 8 mg and in ampoules (thiocolchicoside, muscle relaxant).

Currently the company has employed about 130 people  including those from from Chervensky district.